Introduction.-B-cells have immuno-regulatory function acting as antigen-presenting cells. A separate subset of IL-10 producing B-cells (Bregs) has been identified in humans and mice regulating T-cell mediated immunity. In murine models, depletion of Bregs aggravates autoimmune responses. Furthermore, a defect of Bregs in human systemic lupus erythematosus has been reported. In the present study, we hypothesized that Bregs may be diminished or also defective in ANCA-associated vascultis (AAV). Methods.-Twelve healthy controls (HC) and 31 patients with AAV were enrolled. 22 AAV patients were in remission (AAV-r). 16 out of the AAV-r patients were untreated, 6 received immunosuppressive therapy at the time of sampling. 9 AAV patients presented with active disease (AAV-a) at the time of sampling. Bregs were defined as IL-10+ CD19+ B-cells. Bregs and T-cell subsets were determined via flow cytometry. Data is given as mean AE standard deviation.
Interleukin-21, B cell activating factor and unmethylated CpG oligodeoxynucleotides synergize in promoting anti-Proteinase 3 autoantibody production in vitro 
